21st Century Oncology, LLC, and the American Board of Radiology, Bethesda, Maryland.
Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.
Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):11-7. doi: 10.1016/j.ijrobp.2013.09.040. Epub 2013 Nov 15.
In early 2011, a dialogue was initiated within the Board of Directors (BOD) of the American Society for Radiation Oncology (ASTRO) regarding the future of the basic sciences of the specialty, primarily focused on the current state and potential future direction of basic research within radiation oncology. After consideration of the complexity of the issues involved and the precise nature of the undertaking, in August 2011, the BOD empanelled a Cancer Biology/Radiation Biology Task Force (TF). The TF was charged with developing an accurate snapshot of the current state of basic (preclinical) research in radiation oncology from the perspective of relevance to the modern clinical practice of radiation oncology as well as the education of our trainees and attending physicians in the biological sciences. The TF was further charged with making suggestions as to critical areas of biological basic research investigation that might be most likely to maintain and build further the scientific foundation and vitality of radiation oncology as an independent and vibrant medical specialty. It was not within the scope of service of the TF to consider the quality of ongoing research efforts within the broader radiation oncology space, to presume to consider their future potential, or to discourage in any way the investigators committed to areas of interest other than those targeted. The TF charge specifically precluded consideration of research issues related to technology, physics, or clinical investigations. This document represents an Executive Summary of the Task Force report.
2011 年初，美国放射肿瘤学会（ASTRO）理事会内部就该专业基础科学的未来展开了对话，主要集中在放射肿瘤学基础研究的现状和潜在未来方向上。在考虑到所涉及问题的复杂性和所承担任务的精确性质之后，2011 年 8 月，理事会成立了癌症生物学/放射生物学工作组（TF）。该工作组的任务是从与放射肿瘤学现代临床实践以及我们的学员和主治医生的生物科学教育相关的角度，对放射肿瘤学基础（临床前）研究的现状进行准确的描述。该工作组还被要求就可能最有可能维持和进一步发展放射肿瘤学作为一个独立而充满活力的医学专业的基础生物学研究调查的关键领域提出建议。该工作组的服务范围不包括考虑更广泛的放射肿瘤学领域内正在进行的研究工作的质量，假设考虑它们的未来潜力，或以任何方式阻碍致力于除目标领域以外的其他领域的研究人员。该工作组的任务专门排除了与技术、物理或临床研究相关的研究问题的考虑。本文件代表工作组报告的执行摘要。
